Cargando…
The feasibility of PETHEMA ALL-96 regimen on treatment of patients with acute lymphoid leukemia
BACKGROUND: Asparaginase-based treatment regimen for acute lymphocytic leukemia (ALL) is considered as feasible, but there is still a lack of data. In this study, considering the results of other regimen that were not optimum in previous studies. Here, we aimed to investigate the feasibility of PETH...
Autores principales: | Ashrafi, Farzaneh, Sadeghi, Alireza, Derakhshandeh, Ali, Oghab, Padideh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199372/ https://www.ncbi.nlm.nih.gov/pubmed/37213449 http://dx.doi.org/10.4103/jrms.jrms_4_22 |
Ejemplares similares
-
Prognostic Factors and Outcome of Patients with Adult Acute Lymphoblastic Leukemia Treated with the Hyper-CVAD Regimen: A Retrospective Study
por: Malakoutikhah, Zahra, et al.
Publicado: (2023) -
A pediatric regimen for adolescents and young adults with Philadelphia chromosome‐negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial
por: Ribera, Josep‐Maria, et al.
Publicado: (2020) -
Massive Splenomegaly: A Rare Presentation of Megaloblastic Anemia
por: Gholipur-Shahraki, Tahereh, et al.
Publicado: (2021) -
The Differentiation Syndrome in Patients with Acute Promyelocytic Leukemia: Experience of the Pethema Group and Review of the Literature
por: Montesinos, Pau, et al.
Publicado: (2011) -
Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience
por: Labrador, Jorge, et al.
Publicado: (2022)